Douglas K. Bishop to Interleukin-2
This is a "connection" page, showing publications Douglas K. Bishop has written about Interleukin-2.
Connection Strength
0.091
-
The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant. 2002 Apr; 2(4):323-32.
Score: 0.050
-
New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol. 2012 Jan 15; 188(2):892-901.
Score: 0.024
-
Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg. 2006 Jun; 117(7):2250-8.
Score: 0.017